Oncology & Cancer

Immunotherapy improves survival in advanced bladder cancer patients

An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...

Oncology & Cancer

Care at high-volume facility may cut mortality in multiple myeloma

(HealthDay)—Patients with multiple myeloma (MM) may receive a survival benefit from being treated at high-volume facilities, according to a study published in the September issue of the Journal of the National Comprehensive ...


ACS: accepting liver from older donor better than waiting

(HealthDay)—Accepting a liver from an older liver donor (OLD) is associated with long-term survival benefit, according to a study presented at the annual meeting of the American College of Surgeons, held from Oct. 21 to ...

page 1 from 9